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Abstract.  The glial fibrillary acidic protein (GFAP) is 
a glial-specific intermediate filament protein, which is 
expressed in astrocytes in the central nervous system, 
as well as in astrocytoma cell lines. To investigate  the 
function of GFAP, we have studied the human astrocy- 
toma cell line, U251,  which constitutively expresses 
GFAP and vimentin in the same 10-rim filaments. These 
cells respond to neurons in vitro in the same way as 
primary astrocytes: they withdraw from the cell cycle, 
support neuronal cell survival and neurite outgrowth, 
and they extend complex, GFAP-positive  processes.  To 
determine the role of GFAP in these responses, we 
have specifically suppressed its expression by stably 
transfecting the U251  cells with an antisense GFAP 
construct. Two stable antisense cell lines from sep- 
arate transfections were isolated and were shown to be 
GFAP negative by Northern and Western blot analy- 
ses, and by immunofluorescence studies. The antisense 
cell lines were inhibited in their ability to extend 
significant glial processes in response to neurons. In 
culture with primary neurons, the average  increase in 
process length of the U251  cells was nearly 400%, as 
compared to only 14%  for the antisense transfectants. 
The other neuron induced responses of astrocytes, i.e., 
proliferative arrest and neuronal support, were not 
affected in these cell lines. These data support the 
conclusion that the glial-specific intermediate filament 
protein, GFAP, is required for the formation of stable 
astrocytic processes in response to neurons. 
I 
NTERMEDIATE filaments are 8-10 nm cytoskeletal struc, 
tures composed of a class of proteins exhibiting a high 
degree of cell-type specificity. Thus neurofilaments are 
found in neuronal cells, desmin in muscle cells, the keratins 
in epithelial cells, whereas astrocytes express the glial spe- 
cific, glial fibrillary acidic protein (GFAP).~ In addition, vi- 
mentin, which is present in cells of mesenchymal origin can 
be expressed in astrocytes, as well as in most ceils in tissue 
culture. The functions of the intermediate filament proteins 
are unknown, although their tissue specificity suggests that 
they are involved in specialized functions related to the dif- 
ferentiation state of the cell. 
During development of the central nervous system, neu- 
rons are born at the ventricular  surface and then migrate 
along astrocytic processes toward their ultimate destination, 
where astrocytes provide the scaffolding and trophic support 
required for neuronal positioning (Rakic, 1972, 1981; Hatten 
et al., 1988). These observations suggest that the extension 
of astrocytic processes,  which are rich in GFAP, is critical 
to CNS organogenesis. 
In tissue culture systems, primary astrocytes respond to 
1. Abbreviations used in this paper: AS, glial fibrillary acid protein-ncga- 
five; GFAP, glial fibrillary acidic protein;  PD, phosphate-buffered  saline 
without  calcium  and  magnesium;  MAP,  anti-microtubule-assoeiated 
protein. 
the presence of neurons by withdrawing from the cell cycle, 
extending complex processes, and promoting neuronal sur- 
vival and outgrowth (Hatten and Shelanski,  1988; Hatten, 
1987; Gasser and Hatten,  1990). These responses appear to 
resemble the behavior of primary astrocytes in situ.  Most 
prominent among these neuron-induced responses is the ex- 
tension of  lengthy and complex GFAP-positive  processes; as- 
trocytic cells grown in the absence of neurons have a flat, 
fibroblastic appearance, with little or no process formation 
(Hatten, 1985). A number of rodent and human astrocytoma 
cell lines display similar neuron-induced responses in vitro 
(Hatten and Shelanski, 1988). One of these, the human as- 
trocytoma cell line U251, constitutively expresses GFAP and 
vimentin in the same 10-nm filaments (Westermark,  1973; 
Wang et al.,  1984). 
To investigate the role of GFAP in these phenomena,  we 
specifically interfered with GFAP expression in U251 cells 
by stably transfecting them with an antisense construct of 
the GFAP gene and characterized the responses of  the GFAP- 
negative (AS) cells to the addition of  neurons. The data show 
that the AS cells are unable to express GFAP, even in the 
presence of  neurons, and that unlike the parent U251 cell line, 
they do not establish the complex,  stable processes in re- 
sponse to neurons. The absence of GFAP and astrocytic pro- 
cesses,  were the only observed  alterations  in these stable 
transfectants. 
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Piasmid Construction and Tmnsfection 
All molecular biology buffers, reagents and enzymes were purchased from 
Boehringar Mannheim  Biochemicais, Inc., Indianapolis,  IN. The coding re- 
gion of the murine GFAP cDNA (Lewis et ai., 1984) was excised from the 
pUC9 vector at the Sai I-Eco RI restriction sites, and the 1.2-kb fragment 
was purified as described (Vogelstein and Gillespie,  1979). The ends were 
filled in with the large Klenow fragment of Facherichia coli DNA polymer- 
ase I, and Hind HI liners were added, trimmed back, and annealed to the 
pSV2i plasmid (Chin and Liem, 1989), which had been cut at a unique Hind 
HI restriction site (the plasmid was the generous gift of Drs. H. Samuels 
and B. Forman, New York University Medical Center, New York). Compe- 
tent HBIOI ceils were transformed with this plasmid, and plated on ampicil- 
lin plates.  Transformants  were  picked and transferred to  nitrocellulose 
filters, which were then hybridized with a 32p ulck-translated  GFAP coding 
cDNA (Davis et ai.,  1986). Colonies that hybridized with the probe were 
expanded and plasmid analysis  was carried out (Taylor and Brose,  1988). 
The orientation  of the pSV2i/GFAP plasmid in the U'ansformants was deter- 
mined by restriction enzyme analysis.  The antisense orientation plasmid, 
pSV2i/as-GFAP, was expanded and purified.  The plasmid was linearized at 
a unique Barn HI site, and the neo resistance gene under the control of the 
SV-40 promoter was inserted as a cartridge (Chin and Liem, 1989), result- 
ing in the new plasmid, pSV2neo/asGFAR  Bacterial cells were infected 
with this plasmid, and the cycle of analysis, purification,  and expansion was 
repeated.  The plasmid was linearized at the unique Eco RI site and the linear 
DNA was transfected into U251 cells using the calcium phosphate method 
(Wigler et al.,  1979). 
3 d after transfection,  the cells were switched into selection medium that 
contained I rag/m] of the neomycin analogue G418 (Gibco Laboratories, 
Grand Island, NY). Foci of G418 resistant cells were picked using a cloning 
ring, and expanded.  Colonies were evaluated for the expression  of the GFAP 
gene product by immunofluorescence.  Colonies that were virtually nonreac- 
tive with the anti-GFAP antibody were  cloned to the single cell stage 
(Mellman et al., 1980), and reevaluated by Northern blot, Western blot, and 
immunofluorescence  analyses. In all cases, U251 cells transfected only with 
the neomycin resistance gene were included as controls. 
Northern Blot Analysis 
Total RNA was isolated from each cell line on CsC1 gradients, and 20 mg 
of  material  were  electrophorcticaily  separated  and  transferred  to  a 
Genescreen nylon filter (New England Nuclear,  Boston, MA), as previ- 
ously described (Davis et ai., 1986). The filters were probed with 32p nick- 
translated cDNA of either the 5' end of the mouse GFAP gene (Lewis et 
al.,  1984), or the 5' end of the human vimentin gene (the kind gift of Dr. 
R. Baserga,  Temple University), overnight at 65°C.  The filters were then 
washed sequentially at 65°C, three times in 2x SSC, 0.1% SDS; twice in 
ix SSC,O.I%  SDS; and once in 0.1x SSC, 0.1% SDS, dried, and exposed 
to x-ray film. 
Western Blot Analysis 
Cytoskeletai preparation of U251 and AS cells were generated essentially 
as described (Chin and Liem,  1989).  Briefly, cells were  grown to con- 
fluence,  washed extensively  with PBS,  scraped from the flask,  pelleted, 
and washed twice with PBS. The cells were extracted with 1% Triton X-IO0 
in phosphate buffered saline without calcium and magnesium (PD), with 
2 mM phenylmethylsulfonylfluoride;  the extracts were treated for 30 rain 
at room temperature with 0.5 mg/mi of DNAase in PD with 10 mM CaCI2 
(all from Sigma Chemical Co.,  St.  Louis,  MO).  The Triton-insoluble 
cytoskeletai  extracts were pelleted and resuspended in SDS-PAGE sample 
buffer and equal loads of sample were loaded onto a 7.5% polyacrylamide 
gel and run at constant current (Laemmli, 1970).  The proteins were dec- 
troblotted onto uultrocellulose paper in 10 mM Caps buffer,  10% MeOH, 
pH 11.4 (Matsudaira, 1987). The blots were probed with monocioual anti- 
GFAP and anti-vimentin  antibodies followed by peroxidase-conjngated  goat 
anti-mouse second antibody (Boehringer Mannheim Biochemicais,  Inc.). 
The reaction product was visualized with diaminobenzidine (Sigma Chemi- 
cal Co.) and hydrogen peroxide. 
Cell Culture 
Astrocytoma ceils were grown in T75 tissue culture flasks (Falcon Labware, 
Becton, Dickinson & Co., Lincoln Park, NJ) in Dulbecco's minimal essen- 
tial medium, supplemented with 10% heat-inactiveted  fetal calf serum, 5 % 
heat-inactivated  horse serum, MEM nonessentiul amino acids,  penicillin, 
and sueptomycin (all from Gibeo Laboratories) and 20 mM Hepes (Sigma 
Chemical Co.). The AS ceil tines were grown in the above medium sup- 
plemented with 1 mg/ml of G418 (Gibco Laboratories). All cultures were 
maintained at 37°C and 7% CO2 at controlled humidity. 
Primary cerebellar granule cell neurons were prepared from postnatal 
day-4 Sprngue Dawley rats, as described by Hatten (1987). The purity of 
the preparations was assessed by staining with anti-GFAP antibodies. Astro- 
cyte contamination in the neuronal preparations was always 1% or less. 
The C17 cells are a retroviraily  transformed preneuroual cell line which 
has been described elsewhere (Weinstein et ai., 1990; Ryder et al., 1990). 
Unless otherwise specified,  all tissue culture assays were carried out in 
Lab-Tek 8-well tissue culture slides (Miles Laboratories Inc., Naperville, 
ILL in 0.2-0.4 ml of complete medium. The slides were coated with 100 
mg/ml of poly-D-lysine  (Sigma  Chemical Co.).  Cells were  incubated at 
37°C in 7% CO2 at controlled humidity. 
In coculture experiments,  the astrocytic  cells were mixed with culture 
partners in suspension,  and the cells were allowed to settle to the substrate. 
lmmunocytochemistry 
Cells were grown described above for 24--48 h, after which the cultures 
were fixed. Cells to be evaluated for the presence of internal antigens were 
fixed in ice cold methanol at -20°C for 7 rain and washed by immersion 
in PD for 20 rain. Nonspecific binding was blocked by incubation in a solu- 
tion of 10% fetal calf serum and 10% normal goat serum in PD for 30 rain 
at room temperature.  The blocking solution was removed and primary anti- 
bodies were added for 60 min at room temperature. The slides were washed 
by immersion in PD for I h, then incubated for 20 rain at room temperature 
in fluorescein-  or  rhodamine-conjogated  goat anti-rabbit or goat anti- 
mouse Ig (Antibodies, Inc., Davis, CA), diluted to a final concentration of 
1:300, and washed a final time in PD for 1 h. The slides were mounted in 
16% polyvinyl  alcohol (Sigma Chemical Co.), 33% glycerol  in PD, and 
viewed under a Nikon Optiphot microscope fitted for fluorescence  micros- 
copy. In double-labeling experiments the slides were treated identically ex- 
cept that both primary antibodies were added simultaneously,  followed by 
a cocktail of both secondary antibodies. 
Rabbit polyclonal anti-giial filament antibody that specifically recognizes 
the GFAP molecule was used at a final concentration of 1:200 (Wang et ai., 
1984).  In double-labeling experiments,  we visualized  the GFAP positive 
cells with a specific rabbit antiserum diluted 1:100, or with a mouse mono- 
clonal antibody, G-A-5 (Boehringer Mannheim Diagnostics,  Inc., Houston, 
TX), diluted 1:50. To image vimentin in the cells we used an anti-vimentin 
rabbit antiserum diluted 1:100 (Wang et al., 1984), or a monoclonal mouse 
antibody specific for the vimentin molecule at a final concentration of 1:50 
(Boehringer Mannheim Diagnostics,  Inc.).  Anti-microtubule-asseciated 
protein 4 (MAP4) is a rabbit antiserum that specifically recognizes the pri- 
mate 210-kD MAP. It was raised as described by Bulinski and Borisy (1980) 
and was the kind gift of Dr. S. Chapin (Columbia University, New York). 
Neurites were stained with NF2B3, a monoclonal antibody that reacts with 
the high molecular mass neurofilament  subunit (Liem et al.,  1985). 
Evaluation of  Gliai Proliferation 
In [3I-I]thymidine incorporation assays, U251 cells were plated 8  x  lif  t to 
1 x  105 cells/well  in I rni of complete medium in 24-well tissue culture 
plates (Falcon Labware),  followed immediately  by membrane preparations 
of C17 ceils at a final concentration of 10 mg/ml (Weinstein et ai.,  1990). 
16 h before harvesting, L0 mCi of tritiated thymidine was added to each 
well. Cells were harvested by trypsinization, and immediately upon release 
from the substrate four times the volume of complete medium was added 
and the cells pelleted.  Each cell pellet was resuspended in 1 mi of trichloro- 
acetic acid and filtered onto disk filter (GF/C; Whatman, Mainstone, UK). 
Each experimental point was done in triplicate.  The standard error of the 
mean was always <15%. The radioactive incorporation in U251 cells cul- 
tured in the absence of effector cell membranes was considered as 100% 
incorporation (control).  Percent incorporation was calculated  as  100  x 
(mean of the counts in the experimental group/control). 
Evaluation of  Astrocytoma Process Outgrowth 
U251 cells or AS cells were cultured with purified primary granule cell neu- 
rons from cerebellum. After 48 h the cultures were fixed and double stained 
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immunostaining  was used to insure that the AS cells  did not express  GFAP 
in the presence  of neurons, and to assess  the purity of  the granule  cell neu- 
ron preparation. Random  fields (n > 300) were imaged  by immunofluores- 
cence microscopy  and the images  were  recorded  on a video  optical  disk re- 
corder as described (Dunn et al., 1989). The optical disk image  was later 
replayed with the observer  blinded tO culture conditions. The length of the 
processes of  the MAP4 positive  cells was taken  as the distance from  the tip 
of a process  to the middle  of  the cell soma. In cells that had more  than one 
process, each was evaluated. All the MAP4 positive  cells in the field were 
evaluated. Double staining of each field was evaluated by switching from 
rhodarnine to fluorescein  excitation wavelengths. 
Results 
[1251 Cells Stably Transfected with an 
Atisense Construct of the GFAP Gene Fail to React 
with Anti-GFAP  Antibodies 
U251 cells constitutively express the astrocyte specific inter- 
mediate filament protein, GFAP. In an effort to interfere with 
the expression of this protein we stably expressed antisense 
mRNA of the GFAP gene in the U251 cells. The pSV2i/as- 
GFAP construct (Fig.  1) was introduced into the parent cell 
line by the calcium phosphate precipitation method (Lewis 
et al.,  1984; Wigler et al.,  1979). Transcription of both the 
antisense  GFAP and the  neomycin selection marker were 
driven by the constitutive SV-40 large T promoter (Chin and 
Liem,  1989).  Selection with the neomycin analogue G418 
was maintained continuously,  beginning 3 d  subsequent to 
transfection.  Antibiotic-resistant  colonies  were  randomly 
picked, expanded, and screened for the expression of GFAP 
by immunofluorescence. Colonies that were negative by the 
initial screen were cloned to the single cell stage, expanded, 
and rescreened for the loss of GFAP expression. These colo- 
nies were termed the AS cell lines.  Cells transfection with 
an identical plasmid that contained only the neo resistance 
marker and its viral promoter behaved in all respects in the 
same manner as the untransfected U251 cells. There was no 
observable effect on intermediate filament expression,  cell 
proliferation when neurons  were added~  the ability of the 
cells to support neurons, or to form long,  stable processes 
when neurons were added.  Two GFAP-negative cell lines, 
AS2 and AS3, each from separate transfection experiments, 
were characterized in detail. 
AS2 and AS3 failed to react with a polyclonal rabbit anti- 
body that specifically recognizes the GFAP protein (Fig. 2, 
c and e), whereas U251  cells stain intensely with the anti- 
serum (Fig. 2 a). All the lines continue to react with a mono- 
clonal  antibody  directed  against  vimentin  (Fig.  2,  b,  d, 
and f). 
Western blot analysis of cytoskeletal preparation of U251 
cells using G-A-5 anti-GFAP monoclonal antibody revealed 
a major band that migrated with an apparent molecular mass 
of 55,000 D, while AS2 and AS3 cytoskeletal preparations 
failed to react with the antibody (Fig. 3). The same prepara- 
tions from all three cell lines appeared to react equally with 
a monoclonal antibody against vimentin (Fig. 3, lanes 4-6). 
Expression of  Antisense GFAP mRNA in 
Astrocytoma Cells Results in the Loss of  Hybridization 
to the Native GFAP  mRNA 
Northern blot analysis confirmed the immunofluorescence 
data. Overnight exposure of a blot probed with a nick-trans- 
Figure 1. The plasmid used to introduce the antisense GFAP gene 
into U251 cells. Transcription of the asGFAP and the neomycin re- 
sistance selectable marker are driven by separate viral SV-40 early 
promoter sequences. The remaining plasmid DNA sequences en- 
code the bacterial ampicillin resistance gene and stop codons. The 
arrows indicate the direction of transcription. 
lated GFAP eDNA with mRNA showed hybridization from 
the parent cells, but not with mRNA from the AS2 or AS3 
cells (Fig. 4, lanes 1-3). Fig 4, lanes 4-6 show the same filter 
exposed for 3  d,  revealing no further hybridization of the 
mRNA from the AS2 or AS3 cells with the GFAP probe. 
mRNA from the parent cell line, as well as the asGFAP cells, 
hybridized strongly to a eDNA probe for vimentin (Fig. 4, 
lanes 7-  9, overnight exposure). The absence of any signal for 
GFAP in the AS2 and AS3 cells could be due to the degrada- 
tion of double-stranded RNA. 
AS Cells Are Contact Inhibited by Neurons 
Neurons  and  neuronal  membrane preparations  have been 
shown to cause primary astrocytes and many astrocytoma 
cells, including the U251 cell line, to exit the cell cycle by 
a  contact  mediated  phenomenon  (Hatten  and  Shelanski, 
1988; Hatten,  1987; Weinstein et al.,  1990). This effect ap- 
pears to be restricted to neurons of CNS origin OVeinstein 
et ai.,  1990). To test whether the expression of the antisense 
mRNA and the subsequent loss of GFAP gene product had 
an effect on this aspect of neuron-astrocyte interaction,  we 
mixed AS  cells or U251  cells with neuronal  membranes. 
Proliferation was measured as a function of tritiated thymi- 
dine incorporation.  As shown in Table I, the AS cells and 
the U251 cells rapidly become quiescent in response to neu- 
ronal membranes. In the absence of neuronal membranes, 
the cells continued to incorporate label. 
AS Cells and U2M Cells Are Indistinguishable 
in their Ability to Promote Neuronal Survival and 
Neurite Outgrowth 
Neuronal survival and neurite extension is dependent on the 
presence ofastrocytes or soluble factors synthesized by these 
cells.  AS2 and AS3,  as well as the control astrocytic ceils 
supported survival and neurite outgrowth of neonatal gran- 
ule cell neurons from cerebellum. We established cocultures 
of granule cell neurons and U251 astrocytoma cells, AS2 or 
Weinstein et al. Antisense mRNA Suppression of GFAP  1207 Figure 3. Western blots of U251 (lanes I and 4), AS2 (lanes 2 and 
5), and AS3 (lanes 3 and 6) cytoskeletal preparations blotted onto 
nitrocellulose  paper  and  reacted  with  monoclonal  antibodies 
against GFAP (lanes 1-3) or vimentin (lanes 4-6). The appearance 
of two bands in the vimentin immunoblot is probably the result of 
protein degradation. 
AS3 cells. The cultures were allowed to grow for 2 d, and 
then the neurites were visualized with NF2B3, a monoclonal 
antibody that recognizes the neurofilament heavy subunit. 
Fig. 5 shows that the extension of neurites in all three types 
ofcoculture  is comparable. Neurons cultured with HeLa  ceils 
quickly disappeared from the cultures, presumably due to 
cell death, while the HeLa ceils continued to proliferate at 
control levels  (data  not  shown).  These results  show  that 
GFAP expression does not appear to be required for gliai- 
specific support of neuronal survival and neurite extension. 
The fact that the AS2 and AS3 cell lines are both able to 
support  neuronal  survival and  process  outgrowth further 
strengthens the argument that these cell lines had most of  the 
properties of the parent U251 cell line. 
AS Cells Fail to Establish Complex, Stable Processes 
in Response to Neurons 
During coculture of astrocytic cells and rodent granule cell 
neurons, the neurons have been shown to be in close associa- 
tion with the astrocytic cells.  The extensive processes of 
these cells provide a template for neuronal positioning and 
migration.  U251  cells have been  shown to be  similar  to 
primary cells:  they extend complex processes that are in- 
tensely immunoreactive with anti-GFAP antibodies (Hatten 
and Shelanski, 1988; Weinstein et al., 1990). We were able 
to take advantage of  the primate specificity of  the anti-MAP4 
antibody to distinguish  the human astrocytic cells,  which 
were both GFAP positive (U251 cells) and GFAP negative 
(AS2 and AS3 cells), from rodent neurons and any contami- 
nating primary astrocytes, which were GFAP positive, but 
Figure 4. Northern blot analysis of GFAP (lanes 1-6) and vimentin 
(lanes 7-9) expression in U251 cells (lane 1 and 4), AS2 cells (lane 
2 and 5), and AS3 cells (lane 3 and 6) shows the absence of GFAP 
mRNA in the asGFAP ceil-lines, and equivalent hybridization in all 
cell lines when probed for vimentin (lane 7, U251; lane 8, AS2; lane 
9, AS3). Lanes 4-6 are a longer exposure of the first three lanes 
(3 d vs. overnight). 
Table L Percent of [3H]Thymidine Incorporated 
Neuronal membranes 
24 h  48 h 
+  -  4- 
U251  14  60  10  100 
AS2  51  98  8  100 
AS3  9  100  11  92 
Neuronal cell membranes inhibit the proliferation of the asGFAP and control 
cell lines. The astrocytic cells were cultured in the presence (+) and absence 
(-) of neuronal membranes and labeled for 16 h before harvesting and liquid 
scintillation counting. Percent incorporation  =  (cpm/cpm of maximal incorpo- 
ration)  x  100. All samples were in duplicate,  and SEM was within  15%  of 
mean value. 
MAP4 negative. Evidence  that antibodies to MAP4 and GFAP 
label the same cells and their processes is shown in Figs. 6, 
a and b, where the parent U251 cells cocultured with neurons 
were double labeled with the two antibodies. No differences 
can be observed in the staining patterns of the two antibod- 
ies. The addition of neurons to the AS cells did not result 
in the induction of GFAP protein expression. In multiple ex- 
periments, only a single AS cell was ever observed to double 
label with the anti-MAP4 antibody and the anti-GFAP anti- 
body, whereas the untransfected U251 cells were always dou- 
ble labeled. 
To test the effect of the suppression of GFAP on gliai pro- 
cess formation, we established cocultures of U251, AS2, or 
AS3 cells and primary granule cell neurons. The neurons ap- 
peared to be in close association with all of the astrocytic 
cells lines and grow out processes. Fig. 6, c, e, and f  show 
the  phase-contrast  images  obtained  from  these  cultures, 
which confirm the presence of neurites previously demon- 
strated in Fig. 5. However, by anti-MAP4 staining, we could 
observe a striking difference in the process formation of the 
Figure 2. Double-immunofluorescence labeling of the parent U251 cells (a and b), and the stable transfectants AS2 (c and d), and AS3 
(e and f) with a polyclonal antiserum against GFAP (a, c, and e) and a monoclonal anti-vimentin antibody (b, d, and f), using fluorescein- 
and rhodamine-labeled secondary antibodies. The same fields are shown in each pair of micrographs. These results demonstrate that the 
two U251 lines transfected with the antisense construct have become GFAP negative, but still express vimentin at similar levels as the 
untransfected cells. Bar, 10 ram. 
Weinstein et al. Antisense mRNA Suppression of GFAP  1209 Figure 5. Interactions of astroeytic cells and neurons.  Cocultures of the astrocytic cells and granule cell neurons from neonatal rat cerebel- 
lum were analyzed for the ability of the AS cells to support neurite  outgrowth.  All the astrocytic  cell lines  supported  neurite  outgrowth, 
as assessed  by neurite  staining  with NF2B3,  a monoclonal antibody that reacts  with the neurofilament  heavy subunit  (U251, AS2, and 
AS3, a-c, respectively).  Bar,  20 mm. 
two AS cell lines (Fig. 6, fand h), when compared with the 
parent U251 cell line (Fig. 6 c). The two AS cell lines were 
unable to extend the long, complex processes that were typi- 
cal of cocultures of astrocytes and neurons. 
To quantitate  the inhibition of glial process formation in 
the AS2 and AS3 cells, we carried out morphometric analy- 
sis of the astrocytic ceils in the presence and absence of neu- 
rons. Measurements were taken from the tip of a glial pro- 
cess to the middle of the cell soma. As outlined in Table II, 
there was no significant difference between the U251  cells 
and the AS cells in the absence of neurons. However, the ad- 
dition of neurons to the AS cells did not result in these cells 
undergoing the dramatic changes that are typical of mixed 
astrocyte-neuronal  cultures:  the  mean  change in  cell  size 
was small, with an increase in process length of only 14%. 
The addition of neurons to the U251 cells resulted in an in- 
crease of  average process length of 389 %. It appears unlikely 
that  this  difference  was  due  to  transfection  alone,  as  the 
neomycin-transfected cells responded like the untransfected 
cells. 
Discussion 
The tissue-specific expression of the intermediate  filament 
proteins suggests that these proteins play a role in the special- 
ized function(s) of the cells in which they are expressed. Be- 
cause  the  intermediate  filament  proteins  are  part  of the 
cytoskeletal network, it is logical to consider that these pro- 
teins are involved in a  structural aspect of cell function. In 
the CNS, astrocytes appear to provide structural support for 
neuronal migration and positioning.  We report here on the 
suppression of the expression of GFAP in U251 cells by sta- 
ble  transfection  with  plasmid  DNA  which  constitutively 
Table II. Morphometric Analysis of  Process Length in 
Response to Neurons 
-  Neurons  + Neurons 
U251 Cells  23.8  +  7.10  92.8  5:30 
(% increase in length)  (389%) 
AS Cells  29.78  5:8.85  34.2  5:18 
(% increase in length)  (14%) 
Astrocytic  cells were cultured  either in the presence  or absence of neurons for 
two d. The cultures were fixed and stained with an anti-MAP4 antiserum. The 
length of a given MAP4-positive  process was taken as the distance from the 
ends of the process  to the middle  of the cell soma  (n > 100 for each  experimen- 
tal group). Length is expressed in arbitrary units. 
transcribed  an antisense  mRNA of the GFAP gene,  driven 
by a viral promoter. Our studies suggest that GFAP protein, 
assembled into filaments,  is required for astrocytic cells to 
acquire the structural phenotype that they express in vivo and 
in vitro. 
During the development of the CNS,  astrocytes undergo 
rapid proliferation until the neurons reach their appropriate 
destination and take up residence near the astrocytes, which 
then  withdraw  from  the  cell-cycle.  In  vitro  studies  have 
shown that cell-to-cell contact is essential for the induction 
of astrocyte quiescence.  Our data do not show any require- 
ments for the expression of GFAP protein for this phenome- 
non to occur: AS cells are as sensitive to neuronally medi- 
ated contact inhibition  as the untransfected U251  cells,  or 
control cells transfected with neomycin only. Likewise,  we 
observed  no  differences  between  these  cell  types  in  their 
ability to support neuronal  survival and neurite extension. 
Taken together, the antisense  suppression of GFAP did not 
result in the conversion of an astrocytic cell line,  U251, to 
Figure 6.  AS ceils no longer form long, stable processes in the presence of neurons.  Anti-primate  MAP4 antibody recognizes only the 
human astrocytic cells in mixed neuronal-astrocytic cell cultures.  Where GFAP is present,  MAP4 immunostaining overlaps  with GFAP 
immunostaining.  U251 ceils cocultured with neurons were double labeled with anti-GFAP (a) and anti-MAP4 (b) antibodies, demonstrating 
the colocalization of these two proteins,  and the extensive process formation in response to neurons,  c-h are cocultures  of U251 cells (c 
and d), AS2 cells (e and f), and AS3 cells (g and h) and neurons.  The immunofluorescence  images are the astrocytoma cells stained with 
the anti-MAP4 antibody, demonstrating  the absence of significant process formation by the asGFAP cells in response to neurons.  All three 
cell types support neurite  outgrowth (d, f, and h).  Bar,  10 mm. 
The Journal  of  Cell  Biology,  Volume 112,  1991  1210 a cell line which was devoid of all astrocyte-associated func- 
tions, thus suggesting that the expression of antisense GFAP 
did not interfere with these significant aspects of the biology 
of the U251 cells. 
During the development of some regions of the CNS, a 
switch  occurs in  which  vimentin  is  entirely replaced by 
GFAP; however, other mature astrocytes continue to express 
both proteins (Bovolenta et al.,  1984;  Dalai et al.,  1981). 
Vimentin  message  is  considerably  more  abundant  than 
GFAP mRNA in U251 cells. This is not unreasonable since 
most cells in tissue culture express vimentin in high amounts, 
and the vimentin gene promoter has serum and PDGF re- 
sponse elements (Ferrari et al.,  1986).  Despite the abun- 
dance of vimentin, the structural homologies between vi- 
mentin, and GFAP and their coincident expression, our data 
suggest that vimentin alone is not sufficient to stabilize com- 
plex astrocytic  processes. When stimulated by neurons, U251 
cells,  like primary astrocytes, form extensive, GFAP-rich 
glial processes. In contrast, the AS cell lines undergo only 
a minor shape change in response to neurons, and do not 
overcome the antisense suppression of GFAP expression. 
Northern and Western blot data indicate that these ceil types 
appear to have equivalent amounts of vimentin mRNA and 
protein, and the cells all have intact vimentin filament net- 
works. Therefore, the differences seen in process extension 
in response to neurons cannot be due to differences in vi- 
mentin expression. 
Two lines of evidence support our conclusion that the sup- 
pression of GFAP, and the loss of process forming ability in 
response to neurons in the AS cell lines is a specific result 
of transfection with the antisense GFAP construct. First, the 
two stable antisense constructs we have characterized, AS2 
and AS3, were the results of separate transfection experiments 
and they yielded similar results in terms of GFAP suppres- 
sion and loss of process formation in response to neurons. 
Second, transfection with an identical plasmid containing 
only the neomycin resistance gene and its viral promoter did 
not effect GFAP expression or responsiveness to neurons. 
Taken together, these controls indicate that the effects we 
have characterized are not artifacts of transfection alone, but 
represents a specific suppression of GFAP that results in the 
loss of process formation in response to neurons. 
The data presented in this paper show that removal of a 
cell-specific intermediate filament,  GFAP has  a  dramatic 
effect on the formation of glial processes in the presence of 
neurons even though vimentin expression does not appear to 
be effected. Both vimentin and GFAP are type IH intermedi- 
ate filaments with relatively high homology (Geisler et al., 
1983). The major differences are in the head region, where 
almost no homology is observed between the two molecules. 
The tail regions of the type HI intermediate filaments show 
a greater homology to each other than to other types of inter- 
mediate filaments, however a considerable amount of vari- 
ability is still observed. The unique function of GFAP in the 
formation of stable astrocytie processes could therefore lie 
in either the variable NH2-terminal or COOH-terminal do- 
mains of  the GFAP molecule. Our laboratory is currently un- 
dertaking studies to investigate the importance of the differ- 
ent domains of the GFAP molecule in its unique function. 
The question also remains what effect the addition of neu- 
rons may have on the posttranslational modification of GFAP, 
since our data show that GFAP expression is necessary but 
not sufficient for astrocytic process formation. 13251 cells in 
the absence of neurons express significant levels of GFAP 
protein, but do not extend processes. The induction of pro- 
cess formation appears to be a result of a specific interaction 
between these ceils and CNS neurons. It remains to be deter- 
mined whether this signal leads to posttranslational modifi- 
cation(s) of the glial filament protein, such as phosphoryla- 
tion, which could allow interactions with other cytoskeletal 
elements or cell surface components to lead to the formation 
of the astrocytie processes. Alternatively, it is possible that 
the neuron triggers the expression or modification of other 
cellular proteins, which leads to the initiation of astrocytic 
processes, which in turn are stabilized by the glial specific 
intermediate filament protein. 
In conclusion, we have used an antisense construct of the 
murine GFAP eDNA to suppress the expression of GFAP 
in the U251 human astrocytoma cell line. The suppression 
of GFAP expression results  in the  inability of the  stable 
transformants to extend processes in response to neurons. 
The other responses of astrocytes to the addition of neu- 
rons, i.e., proliferative arrest and neuronal support are not 
effected by the loss of GFAP expression. These data support 
the hypothesis that GFAP functions to stabilize complex giial 
processes. 
We wish to thank Dr. S. Chin for his helpful suggestions with the plasmid 
construction, Mr.  R.  Manson for his photographic assistance, and Mr. 
Michael Kaplan for his editorial expertise and assistance. 
This work was supported by grants NS 21457 and NS 29224 from the 
National Institutes of Health. 
Received for publication 7 September 1990 and in revised form 20 Novem- 
ber  1990. 
References 
Bovolenta,  P., R. K. H. Liem, and C. A. Mason. 1984.  Transitions in form 
and cytoskeletal content  of cerebellar  astroglia  in vivo. Dev. Biol. 102: 
248-259. 
Brunette,  D. M., and  J.  E. Till.  1971.  A method for  the  isolation  of  L-cell  sur- 
face  membranes using  an  aqueous two-phase  polymer  system.  Membr. BioL 
5:215-224. 
Bulinski,  J. C., and G. G. Borisy.  1980.  Immunofluorescence localization  of 
HeLa cell micrombule-associated proteins on microtubules in vitro and in 
vivo. J.  Cell Biol.  87:792-801. 
Chin, S. S. M., and R. K. H. Liem. 1989. Expression  of rat neurofilement  pro- 
teins NF-L and NF-M in transfected non-neuronal cells. Eur. J.  Cell Biol. 
50:475490. 
Dahl, D., D. C. Rueger, A. Bignami, K. Weber, and M. Osborn. 1981. Vimen- 
tin, the 57,000 dalton protein of fibroblasts filaments  is the major cytoskeletal 
component in imrtmhlr¢ gli8.  Fur. J.  Cell Biol. 24:191-196. 
Davis, L. G., M. D. Dibner, and J. F. Battey. 1986. Basic Methods In Molecu- 
lar Biology. Elsevier Science Pubfishing Co., New York. 229 pp. 
Dunn, K. W., T. E. McGraw, and F. R. Mardield.  1989. Iterative fractionation 
of recycling receptors from lysoraally destined ligands in an early sorting en- 
dosome. J.  Cell Biol. 109:3303-3314. 
Ferrari, S., R. Bauini, L. Kaczmarek, S. Rittling, B. Calabretta, J. K. de Riel, 
V.  Philipouls, J.  -F.  Wei, and R.  Baserga.  1986.  Coding sequence and 
growth regulation of the human vimentin gene. Mol. Cell. Biol. 6:3614- 
3620. 
Gasser, U. E., and M. E. Hatten.  1990.  Neuron-gila interactions of rat hip- 
pocampai cells in vitro: glial-gulded neuronal migration and neuronal regula- 
tion of glial difl~ntiation. J. Neurosci.  10:1276-1285. 
Geisler, N., end K. Weber. 1983. Amino acid sequence dala on glial fibrillary 
acidic protein (GFA); implications for the subdivision of intermediate fila- 
ments into epithelial  and non-epithelial  members. EMBO (Eur. Mol. Biol. 
Organ.) J.  2:2059-2063. 
HaVen, M. E. 1987. Neuronal regulation  of astroglial morphology  and prolifer- 
ation in vitro. J.  Cell Biol. 100:384-396. 
Hatten, M. E. 1987. Neuronal inhibition of astroglial cell proliferation is mem- 
brane mediated. J.  Ce//Biol.  104:1353-1360. 
Hatten, M. E., and M. L. Sbelamki. 1988. Mouse cerebelinr granule neurons 
arrest the proliferation of human and rodent astrocytoma cells in vitro. J. 
Neuro. Sci. 8:1447-1453. 
The Journal of Cell Biology, Volume 112,  1991  1212 Hatten, M. E., M. Lynch, R. E. Rydel, J. Sanchez, J. Joseph-Silverstein, D. 
MoscateUi,  and D. B. Rifkin.  1988.  In vitro neurite extension by granule 
neurons is dependent upon astroglial derived fibroblast  growth factor. Dev. 
Biol.  125:280-283. 
Laeramii, U. K. 1970. Cleavage of structural proteins during the assembly of 
the head of bacteriophage T4. Nature  (Lond.). 227:680-685. 
Lewis, S. A., J. M. Balcarek, M. Krek, M. Shelanski, and N. J. Cowan. 1984. 
Sequence of a cDNA clone encoding mouse glial fibrillary  acidic protein: 
structural conservation of intermediate filaments. Proc.  Natl. Acad. Sci. 
USA. 81:2743-2746. 
Liem, R. K. H., S. S. M. Chin, E. Moraru, and E. Wang. 1985. Monoclonal 
antibodies to epitupes on different regions of the 200,000-dalton neurofila- 
merit protein. F.,rp. Cell Res.  156:419-428. 
Matsudaira, P.  1987.  Sequence from picomole quantities of proteins electro- 
blotted  onto polyvinylidene difluoride  membranes. J.  Biol. Chem. 262: 
10035-10038. 
Mellrnan, I. S., R. M. Steinman, J. C. Unkeless, andZ. A. Cohn. 1980. Selec- 
tive iodination and polypeptide composition of pinocyfic vesicles. J.  Cell 
Biol.  86:712-718. 
Rakic, P. 1972. Mode of cell migration to the superficial layers of the monkey 
neocortex. J.  Comp. Neurol.  145:61-84. 
Rakic, P.  1981.  Neuronal-glial interaction during brain development. Trends 
Neurosci.  4:184-187. 
Ryder, E. S., E. Y. Snyder, and C. L. Cepko. 1990. Establishinent  and charac- 
terization of multipotent neural cell lines using retrovims vector-mediated 
oncogene transfer. J. Neurobiol.  21:356-375. 
Taylor, D. E., and E. C. Brose. 1988. Modified Birnbnim-Doly method rapid 
detection of plasmid copy number. Nucleic Acids Res.  16:9056. 
Vogelstein, B., and D. Gillespie.  1979.  Preparative and analytical purification 
of DNA from agarose. Proc. Natl. Acad. Sci. USA. 76:615-619. 
Wang, E., J. G. Calmcross, and R. K. H. Liem. 1984.  Identification  of glial 
filament  protein and vimentin  in the same intermediate filament system  in hu- 
man glioma cells. Proc.  Natl. Acad.  Sci. USA. 81:2102-2106. 
Weinstein, D. E.,  and M.  L. Shelanski, and R. K. H. Liem.  1990.  C17, a 
retrovirally immortalized neuronal cell line, inhibits the proliferation of as- 
trocytes and astrocytoma cells by a  contact mediated mechanism. Glia. 
3:130-137. 
Westermark, B. 1973.  The deficient density-dependent growth control of hu- 
man malignant glioma cells and virus-transformed glia-like cells in culture. 
Int. J.  Cancer.  12:438-451. 
Wiglet, M., A. Pellicer,  S. Silverstein, R. Axel, G. Urlaub, and L. Chasin. 
1979. DNA-mediated transfer of the adenine phosphoribosyltransferase lo- 
cus into mammalian cells. Proc.  Natl. Acad.  Sci. USA. 76:1373-1376. 
Weinstein et aL Antisense mRNA Suppression of GFAP  1213 